Market Value127,549,846
Total Holdings58
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AXDX / Accelerate Diagnostics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PHR / Phreesia, Inc.
SRPT / Sarepta Therapeutics, Inc.
PXD / Pioneer Natural Resources Company
NKTR / Nektar Therapeutics
INBX.V / Inhibrx, Inc.
QDEL / QuidelOrtho Corporation
BMY / Bristol-Myers Squibb Company
IMGN / ImmunoGen, Inc.
ELUT / Elutia Inc.
YTEN / Yield10 Bioscience, Inc.
TVTX / Travere Therapeutics, Inc.
ETRN / Equitrans Midstream Corporation
SILK / Silk Road Medical, Inc
KALV / KalVista Pharmaceuticals, Inc.
TSVT / 2seventy bio, Inc.
AXGN / Axogen, Inc.
NBIX / Neurocrine Biosciences, Inc.
CABA / Cabaletta Bio, Inc.
TXG / 10x Genomics, Inc.
LQDA / Liquidia Corporation
CHRS / Coherus Oncology, Inc.
SWTX / SpringWorks Therapeutics, Inc.
GTHX / G1 Therapeutics, Inc.
HROW / Harrow, Inc.
ARVN / Arvinas, Inc.
KPTI / Karyopharm Therapeutics Inc.
OVV / Ovintiv Inc.
PRTA / Prothena Corporation plc
KNSA / Kiniksa Pharmaceuticals, Ltd.
FHTX / Foghorn Therapeutics Inc.
CGEM / Cullinan Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
WVE / Wave Life Sciences Ltd.
STOK / Stoke Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
BDSX / Biodesix, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
MASI / Masimo Corporation
XENE / Xenon Pharmaceuticals Inc.
HALO / Halozyme Therapeutics, Inc.
CSTL / Castle Biosciences, Inc.
UTHR / United Therapeutics Corporation
DCGO / DocGo Inc.
KROS / Keros Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
IFRX / InflaRx N.V.
BCRX / BioCryst Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
VTYX / Ventyx Biosciences, Inc.
FOLD / Amicus Therapeutics, Inc.
ALKS / Alkermes plc
PGNY / Progyny, Inc.
BHVN / Biohaven Ltd.
CYTK / Cytokinetics, Incorporated
XNCR / Xencor, Inc.